Saquinavir Trough Concentration before and after Switching Nrti to Tenofovir in Patients Treated with Once-Daily Saquinavir Hard Gel Capsule/Ritonavir 1600 Mg/100 Mg
Free accessLetterFirst published online August, 2004
Saquinavir Trough Concentration before and after Switching Nrti to Tenofovir in Patients Treated with Once-Daily Saquinavir Hard Gel Capsule/Ritonavir 1600 Mg/100 Mg
KaulS., BassiK., DamleB., XieJ., GaleJ., KearneyB., & HannaG.Pharmacokinetic evaluation of the combination of atazanavir (ATV), enteric coated dianosine (ddi-EC) and tenofovir disoproxil fumarate (TDF) for a once-daily antiretroviral regimen.43rd Interscience Conference on Antimicrobial Agents & Chemotherapy. 14–17 September 2003, Chicago, Ill., USA. Abstract A-1616.
2.
TaburetA.M., PikettyC., GérardL., VincentI., ChazallonC., ClavelF., CalvezV., AboulkerJ.P., & GirardP.M.Pharmacokinetic parameters of atazanavir/ritonavir when combined to tenofovir in HIV infected patients with multiple treatment failures: a sub-study of Puzzle2-ANRS 107 trial.10th Conference on Retroviruses & Opportunistic Infections. 10–14 February 2003, Boston, Mass., USA. Abstract 537.
3.
Gilead Sciences.Viread (tenofovir disoproxil fumarate) Prescribing Information. October 2003.
4.
BoffitoM., D'AvioloA., Di PerriG., SciandraM., BonaraS., BackD., HillA., MoyleG., NelsonM., HiggsC., TomkinsJ., GazzardB., & PozniakA.Repeated pharmacokinetics of tenofovir disoproxil fumarate (TDF) in HIV-infected adults receiving saquinavir (SQV) hard gel/ritonavir (RTV) 1000/100 mg bid.5th International Workshop on Clinical Pharmacology of HIV Therapy. 1–3 April 2004, Rome, Italy. Abstract 4.19.
5.
DrosteJ.A., Verweij-Van WissenC.P., & BurgerD.M.Simultaneous determination of the HIV drugs indinavir, amprenavir, saquinavir, ritonavir, lopinavir, nelfinavir, the nelfinavir hydroxymetabolite M8, and nevirapine in human plasma by reversed-phase high-performance liquid chromatography.Therapeutic Drug Monitoring2003; 25: 393–399.
